March 10, 2021 — The Alliance for Meat Poultry and Seafood Innovation (AMPS Innovation), a coalition representing makers of cell-cultured protein products, and the US seafood trade association the National Fisheries Institute (NFI) jointly called on the US Food and Drug Administration (FDA) to support requirements for labeling these new products descriptively, accurately and consistently regarding what the products actually are and how they are made.
Based on research by Rutgers professor William Hallman, NFI and AMPS Innovation on Monday urged the FDA to adopt the use of the term “cell-cultured” to support uniform labeling of the products.
The US Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) and the FDA are working together to ensure the safety and labeling of cell-cultured meat, poultry, and seafood products.
FSIS will have oversight of the labeling of cell-cultured meat and poultry, as it does for all meat and poultry sold in the United States, while FDA will oversee the labeling of cell-cultured seafood, as it does for most seafood sold in the United States.